Protean eGov Technologies Limi

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TCS.BO has a market cap of 8.7T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TCS.BO trades at ₹2,441.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TCS.BO's P/E ratio is 18.14. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TCS.BO's ROE of +0.46%. Regarding short-term risk, PROTEAN.BO is more volatile compared to TCS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check TCS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TCS.NS has a market cap of 8.7T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TCS.NS trades at ₹2,440.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TCS.NS's P/E ratio is 18.14. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TCS.NS's ROE of +0.46%. Regarding short-term risk, PROTEAN.BO is more volatile compared to TCS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check TCS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, INFY.NS has a market cap of 5T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while INFY.NS trades at ₹1,267.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas INFY.NS's P/E ratio is 17.31. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to INFY.NS's ROE of +0.30%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INFY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INFY.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, INFY.BO has a market cap of 5T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while INFY.BO trades at ₹1,267.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas INFY.BO's P/E ratio is 17.68. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to INFY.BO's ROE of +0.30%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INFY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INFY.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, HCLTECH.NS has a market cap of 3.6T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while HCLTECH.NS trades at ₹1,357.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas HCLTECH.NS's P/E ratio is 21.76. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to HCLTECH.NS's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HCLTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HCLTECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, HCLTECH.BO has a market cap of 3.6T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while HCLTECH.BO trades at ₹1,357.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas HCLTECH.BO's P/E ratio is 21.76. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to HCLTECH.BO's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HCLTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HCLTECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, WIPRO.NS has a market cap of 2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while WIPRO.NS trades at ₹194.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas WIPRO.NS's P/E ratio is 15.16. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to WIPRO.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is more volatile compared to WIPRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check WIPRO.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, WIPRO.BO has a market cap of 2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while WIPRO.BO trades at ₹194.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas WIPRO.BO's P/E ratio is 15.15. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to WIPRO.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is more volatile compared to WIPRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check WIPRO.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, LTIM.NS has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while LTIM.NS trades at ₹4,298.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas LTIM.NS's P/E ratio is 26.27. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to LTIM.NS's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is more volatile compared to LTIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTIM.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, LTIM.BO has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while LTIM.BO trades at ₹4,302.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas LTIM.BO's P/E ratio is 26.10. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to LTIM.BO's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is more volatile compared to LTIM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTIM.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TECHM.BO has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TECHM.BO trades at ₹1,386.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TECHM.BO's P/E ratio is 25.74. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TECHM.BO's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TECHM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TECHM.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TECHM.NS has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TECHM.NS trades at ₹1,385.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TECHM.NS's P/E ratio is 25.75. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TECHM.NS's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TECHM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TECHM.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, PERSISTENT.BO has a market cap of 708.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while PERSISTENT.BO trades at ₹4,699.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas PERSISTENT.BO's P/E ratio is 40.91. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to PERSISTENT.BO's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to PERSISTENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check PERSISTENT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, PERSISTENT.NS has a market cap of 708.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while PERSISTENT.NS trades at ₹4,698.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas PERSISTENT.NS's P/E ratio is 40.85. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to PERSISTENT.NS's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to PERSISTENT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check PERSISTENT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MPHASIS.NS has a market cap of 395.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MPHASIS.NS trades at ₹2,123.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MPHASIS.NS's P/E ratio is 22.00. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MPHASIS.NS's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MPHASIS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MPHASIS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MPHASIS.BO has a market cap of 395.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MPHASIS.BO trades at ₹2,123.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MPHASIS.BO's P/E ratio is 22.01. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MPHASIS.BO's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MPHASIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MPHASIS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, COFORGE.NS has a market cap of 360.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while COFORGE.NS trades at ₹1,132.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas COFORGE.NS's P/E ratio is 32.10. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to COFORGE.NS's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to COFORGE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check COFORGE.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, COFORGE.BO has a market cap of 360.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while COFORGE.BO trades at ₹1,132.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas COFORGE.BO's P/E ratio is 32.09. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to COFORGE.BO's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to COFORGE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check COFORGE.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, LTTS.BO has a market cap of 353.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while LTTS.BO trades at ₹3,360.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas LTTS.BO's P/E ratio is 28.16. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to LTTS.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is more volatile compared to LTTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTTS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, LTTS.NS has a market cap of 353.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while LTTS.NS trades at ₹3,367.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas LTTS.NS's P/E ratio is 28.08. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to LTTS.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to LTTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTTS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, HEXT.NS has a market cap of 247.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while HEXT.NS trades at ₹436.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas HEXT.NS's P/E ratio is 18.36. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to HEXT.NS's ROE of +0.24%. Regarding short-term risk, PROTEAN.BO is less volatile compared to HEXT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check HEXT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TATATECH.NS has a market cap of 213.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TATATECH.NS trades at ₹548.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TATATECH.NS's P/E ratio is 40.06. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TATATECH.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TATATECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TATATECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TATATECH.BO has a market cap of 213B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TATATECH.BO trades at ₹548.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TATATECH.BO's P/E ratio is 40.18. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TATATECH.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TATATECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TATATECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, REDINGTON.NS has a market cap of 178.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while REDINGTON.NS trades at ₹231.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas REDINGTON.NS's P/E ratio is 10.10. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to REDINGTON.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is more volatile compared to REDINGTON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check REDINGTON.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, REDINGTON.BO has a market cap of 178.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while REDINGTON.BO trades at ₹231.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas REDINGTON.BO's P/E ratio is 10.10. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to REDINGTON.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is more volatile compared to REDINGTON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check REDINGTON.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, KPITTECH.BO has a market cap of 178B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while KPITTECH.BO trades at ₹690.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas KPITTECH.BO's P/E ratio is 26.03. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to KPITTECH.BO's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is less volatile compared to KPITTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check KPITTECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, KPITTECH.NS has a market cap of 177.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while KPITTECH.NS trades at ₹688.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas KPITTECH.NS's P/E ratio is 25.99. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to KPITTECH.NS's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is less volatile compared to KPITTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check KPITTECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, FSL.NS has a market cap of 150B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while FSL.NS trades at ₹227.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas FSL.NS's P/E ratio is 24.30. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to FSL.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to FSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check FSL.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, FSL.BO has a market cap of 150B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while FSL.BO trades at ₹227.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas FSL.BO's P/E ratio is 24.32. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to FSL.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to FSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check FSL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ECLERX.BO has a market cap of 138.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ECLERX.BO trades at ₹1,485.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ECLERX.BO's P/E ratio is 21.18. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ECLERX.BO's ROE of +0.29%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ECLERX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ECLERX.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ECLERX.NS has a market cap of 136.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ECLERX.NS trades at ₹1,486.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ECLERX.NS's P/E ratio is 21.16. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ECLERX.NS's ROE of +0.29%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ECLERX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ECLERX.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ZENSARTECH.BO has a market cap of 128.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ZENSARTECH.BO trades at ₹579.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ZENSARTECH.BO's P/E ratio is 17.58. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ZENSARTECH.BO's ROE of +0.18%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ZENSARTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ZENSARTECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ZENSARTECH.NS has a market cap of 128.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ZENSARTECH.NS trades at ₹579.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ZENSARTECH.NS's P/E ratio is 17.45. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ZENSARTECH.NS's ROE of +0.18%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ZENSARTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ZENSARTECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, BSOFT.NS has a market cap of 101.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while BSOFT.NS trades at ₹364.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas BSOFT.NS's P/E ratio is 21.80. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to BSOFT.NS's ROE of +0.13%. Regarding short-term risk, PROTEAN.BO is more volatile compared to BSOFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check BSOFT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, BSOFT.BO has a market cap of 101.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while BSOFT.BO trades at ₹364.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas BSOFT.BO's P/E ratio is 21.76. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to BSOFT.BO's ROE of +0.13%. Regarding short-term risk, PROTEAN.BO is more volatile compared to BSOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check BSOFT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SONATSOFTW.BO has a market cap of 64.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SONATSOFTW.BO trades at ₹240.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SONATSOFTW.BO's P/E ratio is 14.59. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SONATSOFTW.BO's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SONATSOFTW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SONATSOFTW.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SONATSOFTW.NS has a market cap of 64.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SONATSOFTW.NS trades at ₹240.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SONATSOFTW.NS's P/E ratio is 14.58. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SONATSOFTW.NS's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SONATSOFTW.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SONATSOFTW.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, RSYSTEMINT.BO has a market cap of 63.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while RSYSTEMINT.BO trades at ₹531.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas RSYSTEMINT.BO's P/E ratio is 106.05. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to RSYSTEMINT.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is more volatile compared to RSYSTEMINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMINT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, HAPPSTMNDS.BO has a market cap of 57.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while HAPPSTMNDS.BO trades at ₹383.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas HAPPSTMNDS.BO's P/E ratio is 30.96. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to HAPPSTMNDS.BO's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HAPPSTMNDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HAPPSTMNDS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, HAPPSTMNDS.NS has a market cap of 57.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while HAPPSTMNDS.NS trades at ₹383.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas HAPPSTMNDS.NS's P/E ratio is 30.95. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to HAPPSTMNDS.NS's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HAPPSTMNDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HAPPSTMNDS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MASTEK.BO has a market cap of 45.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MASTEK.BO trades at ₹1,536.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MASTEK.BO's P/E ratio is 12.02. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MASTEK.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MASTEK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MASTEK.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MASTEK.NS has a market cap of 45.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MASTEK.NS trades at ₹1,536.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MASTEK.NS's P/E ratio is 12.00. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MASTEK.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MASTEK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MASTEK.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DATAMATICS.NS has a market cap of 41.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DATAMATICS.NS trades at ₹710.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DATAMATICS.NS's P/E ratio is 21.12. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DATAMATICS.NS's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is more volatile compared to DATAMATICS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check DATAMATICS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DATAMATICS.BO has a market cap of 41.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DATAMATICS.BO trades at ₹710.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DATAMATICS.BO's P/E ratio is 21.11. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DATAMATICS.BO's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is more volatile compared to DATAMATICS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check DATAMATICS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CAMS.BO has a market cap of 31.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CAMS.BO trades at ₹658.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CAMS.BO's P/E ratio is 34.00. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CAMS.BO's ROE of +0.41%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CAMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CAMS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CAMS.NS has a market cap of 31.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CAMS.NS trades at ₹658.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CAMS.NS's P/E ratio is 33.97. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CAMS.NS's ROE of +0.41%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CAMS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CAMS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, RSYSTEMS.NS has a market cap of 30.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while RSYSTEMS.NS trades at ₹262.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas RSYSTEMS.NS's P/E ratio is 17.11. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to RSYSTEMS.NS's ROE of +0.24%. Regarding short-term risk, PROTEAN.BO is more volatile compared to RSYSTEMS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, RSYSTEMS.BO has a market cap of 30.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while RSYSTEMS.BO trades at ₹262.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas RSYSTEMS.BO's P/E ratio is 17.20. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to RSYSTEMS.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is more volatile compared to RSYSTEMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CIGNITITEC.NS has a market cap of 29.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CIGNITITEC.NS trades at ₹1,109.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CIGNITITEC.NS's P/E ratio is 9.76. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CIGNITITEC.NS's ROE of +0.31%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CIGNITITEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CIGNITITEC.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CIGNITITEC.BO has a market cap of 29B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CIGNITITEC.BO trades at ₹1,111.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CIGNITITEC.BO's P/E ratio is 9.62. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CIGNITITEC.BO's ROE of +0.31%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CIGNITITEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CIGNITITEC.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ASMTEC.BO has a market cap of 25.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ASMTEC.BO trades at ₹2,257.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ASMTEC.BO's P/E ratio is 53.79. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ASMTEC.BO's ROE of +0.31%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ASMTEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ASMTEC.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, PROTEAN.NS has a market cap of 20.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while PROTEAN.NS trades at ₹531.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas PROTEAN.NS's P/E ratio is 22.99. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to PROTEAN.NS's ROE of +0.09%. Regarding short-term risk, PROTEAN.BO is less volatile compared to PROTEAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check PROTEAN.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, RPSGVENT.BO has a market cap of 19.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while RPSGVENT.BO trades at ₹622.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas RPSGVENT.BO's P/E ratio is -21.20. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to RPSGVENT.BO's ROE of -0.03%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RPSGVENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RPSGVENT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, RPSGVENT.NS has a market cap of 19.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while RPSGVENT.NS trades at ₹617.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas RPSGVENT.NS's P/E ratio is -21.17. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to RPSGVENT.NS's ROE of -0.03%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RPSGVENT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RPSGVENT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ACCELYA.NS has a market cap of 17.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ACCELYA.NS trades at ₹1,197.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ACCELYA.NS's P/E ratio is 16.35. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ACCELYA.NS's ROE of +0.39%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ACCELYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ACCELYA.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ACCELYA.BO has a market cap of 17.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ACCELYA.BO trades at ₹1,202.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ACCELYA.BO's P/E ratio is 16.35. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ACCELYA.BO's ROE of +0.39%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ACCELYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ACCELYA.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SASKEN.NS has a market cap of 15.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SASKEN.NS trades at ₹1,150.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SASKEN.NS's P/E ratio is 41.23. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SASKEN.NS's ROE of +0.05%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SASKEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SASKEN.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SASKEN.BO has a market cap of 15.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SASKEN.BO trades at ₹1,150.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SASKEN.BO's P/E ratio is 41.01. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SASKEN.BO's ROE of +0.05%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SASKEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SASKEN.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SAKSOFT.NS has a market cap of 14.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SAKSOFT.NS trades at ₹119.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SAKSOFT.NS's P/E ratio is 12.38. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SAKSOFT.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SAKSOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SAKSOFT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SAKSOFT.BO has a market cap of 14.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SAKSOFT.BO trades at ₹119.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SAKSOFT.BO's P/E ratio is 12.37. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SAKSOFT.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SAKSOFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SAKSOFT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MCLOUD.BO has a market cap of 13.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MCLOUD.BO trades at ₹22.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MCLOUD.BO's P/E ratio is 12.21. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MCLOUD.BO's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MCLOUD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MCLOUD.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MCLOUD.NS has a market cap of 13.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MCLOUD.NS trades at ₹22.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MCLOUD.NS's P/E ratio is 12.18. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MCLOUD.NS's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MCLOUD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MCLOUD.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, AURUM.NS has a market cap of 12.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while AURUM.NS trades at ₹170.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas AURUM.NS's P/E ratio is -50.06. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to AURUM.NS's ROE of -0.07%. Regarding short-term risk, PROTEAN.BO is more volatile compared to AURUM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check AURUM.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, AURUM.BO has a market cap of 12.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while AURUM.BO trades at ₹172.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas AURUM.BO's P/E ratio is -49.79. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to AURUM.BO's ROE of -0.07%. Regarding short-term risk, PROTEAN.BO is more volatile compared to AURUM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check AURUM.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ORIENTTECH.NS has a market cap of 12.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ORIENTTECH.NS trades at ₹269.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ORIENTTECH.NS's P/E ratio is 56.56. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ORIENTTECH.NS's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ORIENTTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ORIENTTECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DSSL.NS has a market cap of 11.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DSSL.NS trades at ₹909.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DSSL.NS's P/E ratio is 13.35. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DSSL.NS's ROE of +0.36%. Regarding short-term risk, PROTEAN.BO is more volatile compared to DSSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check DSSL.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DSSL.BO has a market cap of 11.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DSSL.BO trades at ₹910.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DSSL.BO's P/E ratio is 13.32. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DSSL.BO's ROE of +0.36%. Regarding short-term risk, PROTEAN.BO is more volatile compared to DSSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check DSSL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, EXPLEOSOL.NS has a market cap of 11.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while EXPLEOSOL.NS trades at ₹752.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas EXPLEOSOL.NS's P/E ratio is 10.48. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to EXPLEOSOL.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to EXPLEOSOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check EXPLEOSOL.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, EXPLEOSOL.BO has a market cap of 11.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while EXPLEOSOL.BO trades at ₹746.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas EXPLEOSOL.BO's P/E ratio is 10.46. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to EXPLEOSOL.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is more volatile compared to EXPLEOSOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check EXPLEOSOL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MMWL.BO has a market cap of 10.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MMWL.BO trades at ₹9.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MMWL.BO's P/E ratio is 231.25. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MMWL.BO's ROE of +0.03%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MMWL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MMWL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, 3IINFOTECH.BO has a market cap of 9.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while 3IINFOTECH.BO trades at ₹54.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas 3IINFOTECH.BO's P/E ratio is 111.67. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to 3IINFOTECH.BO's ROE of +0.08%. Regarding short-term risk, PROTEAN.BO is more volatile compared to 3IINFOTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check 3IINFOTECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, BGDL.BO has a market cap of 9.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while BGDL.BO trades at ₹92.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas BGDL.BO's P/E ratio is 321.50. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to BGDL.BO's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is less volatile compared to BGDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check BGDL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, VAKRANGEE.NS has a market cap of 6.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while VAKRANGEE.NS trades at ₹6.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas VAKRANGEE.NS's P/E ratio is 54.09. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to VAKRANGEE.NS's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is more volatile compared to VAKRANGEE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check VAKRANGEE.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, VAKRANGEE.BO has a market cap of 6.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while VAKRANGEE.BO trades at ₹6.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas VAKRANGEE.BO's P/E ratio is 54.09. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to VAKRANGEE.BO's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is more volatile compared to VAKRANGEE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check VAKRANGEE.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, XCHANGING.BO has a market cap of 6.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while XCHANGING.BO trades at ₹58.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas XCHANGING.BO's P/E ratio is 10.74. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to XCHANGING.BO's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to XCHANGING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check XCHANGING.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, XCHANGING.NS has a market cap of 6.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while XCHANGING.NS trades at ₹58.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas XCHANGING.NS's P/E ratio is 10.71. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to XCHANGING.NS's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to XCHANGING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check XCHANGING.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ADSL.NS has a market cap of 5.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ADSL.NS trades at ₹105.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ADSL.NS's P/E ratio is 17.88. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ADSL.NS's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ADSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ADSL.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ADSL.BO has a market cap of 5.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ADSL.BO trades at ₹105.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ADSL.BO's P/E ratio is 17.83. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ADSL.BO's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ADSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ADSL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MINDTECK.NS has a market cap of 5.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MINDTECK.NS trades at ₹183.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MINDTECK.NS's P/E ratio is 19.65. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MINDTECK.NS's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MINDTECK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MINDTECK.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, NINSYS.BO has a market cap of 5.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while NINSYS.BO trades at ₹297.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas NINSYS.BO's P/E ratio is 17.95. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to NINSYS.BO's ROE of +0.49%. Regarding short-term risk, PROTEAN.BO is less volatile compared to NINSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check NINSYS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, MINDTECK.BO has a market cap of 5.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while MINDTECK.BO trades at ₹185.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas MINDTECK.BO's P/E ratio is 19.52. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to MINDTECK.BO's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MINDTECK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MINDTECK.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, NINSYS.NS has a market cap of 5.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while NINSYS.NS trades at ₹293.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas NINSYS.NS's P/E ratio is 17.74. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to NINSYS.NS's ROE of +0.49%. Regarding short-term risk, PROTEAN.BO is more volatile compared to NINSYS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check NINSYS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ONWARDTEC.BO has a market cap of 5.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ONWARDTEC.BO trades at ₹248.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ONWARDTEC.BO's P/E ratio is 11.92. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ONWARDTEC.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ONWARDTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ONWARDTEC.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, ONWARDTEC.NS has a market cap of 5.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while ONWARDTEC.NS trades at ₹248.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas ONWARDTEC.NS's P/E ratio is 11.74. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to ONWARDTEC.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ONWARDTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ONWARDTEC.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, XTGLOBAL.BO has a market cap of 4.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while XTGLOBAL.BO trades at ₹30.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas XTGLOBAL.BO's P/E ratio is 46.52. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to XTGLOBAL.BO's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to XTGLOBAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check XTGLOBAL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SIGMA.BO has a market cap of 4.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SIGMA.BO trades at ₹39.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SIGMA.BO's P/E ratio is 16.19. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SIGMA.BO's ROE of +0.51%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SIGMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SIGMA.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SIGMA.NS has a market cap of 4.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SIGMA.NS trades at ₹40.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SIGMA.NS's P/E ratio is 16.10. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SIGMA.NS's ROE of +0.51%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SIGMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SIGMA.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TERASOFT.NS has a market cap of 4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TERASOFT.NS trades at ₹338.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TERASOFT.NS's P/E ratio is 19.88. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TERASOFT.NS's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TERASOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TERASOFT.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, TERASOFT.BO has a market cap of 4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while TERASOFT.BO trades at ₹337.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas TERASOFT.BO's P/E ratio is 19.89. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to TERASOFT.BO's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is more volatile compared to TERASOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check TERASOFT.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DIGISPICE.NS has a market cap of 4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DIGISPICE.NS trades at ₹17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DIGISPICE.NS's P/E ratio is 63.04. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DIGISPICE.NS's ROE of +0.00%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DIGISPICE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DIGISPICE.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, DIGISPICE.BO has a market cap of 4B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while DIGISPICE.BO trades at ₹17.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas DIGISPICE.BO's P/E ratio is 63.00. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to DIGISPICE.BO's ROE of +0.00%. Regarding short-term risk, PROTEAN.BO is more volatile compared to DIGISPICE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check DIGISPICE.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CYBERTECH.NS has a market cap of 3.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CYBERTECH.NS trades at ₹111.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CYBERTECH.NS's P/E ratio is 10.04. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CYBERTECH.NS's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CYBERTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CYBERTECH.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, CYBERTECH.BO has a market cap of 3.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while CYBERTECH.BO trades at ₹111.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas CYBERTECH.BO's P/E ratio is 10.04. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to CYBERTECH.BO's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CYBERTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CYBERTECH.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, INSPIRISYS.BO has a market cap of 3.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while INSPIRISYS.BO trades at ₹83.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas INSPIRISYS.BO's P/E ratio is 8.44. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to INSPIRISYS.BO's ROE of +0.82%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INSPIRISYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INSPIRISYS.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, INSPIRISYS.NS has a market cap of 3.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while INSPIRISYS.NS trades at ₹81.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas INSPIRISYS.NS's P/E ratio is 8.28. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to INSPIRISYS.NS's ROE of +0.82%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INSPIRISYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INSPIRISYS.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SOFTSOL.BO has a market cap of 2.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SOFTSOL.BO trades at ₹201.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SOFTSOL.BO's P/E ratio is 23.68. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SOFTSOL.BO's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is more volatile compared to SOFTSOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check SOFTSOL.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SILVERTUC.NS has a market cap of 2.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SILVERTUC.NS trades at ₹111.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SILVERTUC.NS's P/E ratio is 42.64. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SILVERTUC.NS's ROE of +0.24%. Regarding short-term risk, PROTEAN.BO is more volatile compared to SILVERTUC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check SILVERTUC.NS's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, SILVERTUC.BO has a market cap of 2.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while SILVERTUC.BO trades at ₹111.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas SILVERTUC.BO's P/E ratio is 42.30. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to SILVERTUC.BO's ROE of +0.24%. Regarding short-term risk, PROTEAN.BO is more volatile compared to SILVERTUC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check SILVERTUC.BO's competition here

PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PROTEAN.BO stands at 20.8B. In comparison, 3IINFOLTD.BO has a market cap of 2.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹531.35, while 3IINFOLTD.BO trades at ₹13.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PROTEAN.BO currently has a P/E ratio of 23.02, whereas 3IINFOLTD.BO's P/E ratio is 4.25. In terms of profitability, PROTEAN.BO's ROE is +0.09%, compared to 3IINFOLTD.BO's ROE of +0.76%. Regarding short-term risk, PROTEAN.BO is less volatile compared to 3IINFOLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check 3IINFOLTD.BO's competition here